Biotechnology
A Response to ‘Another Legislative Attempt to Revive Gene Patenting’
Including purified and isolated materials as eligible subject matter under 35 U.S.C. ยงย 101 can benefit patients, researchers, and innovation.
A Response to ‘Another Legislative Attempt to Revive Gene Patenting’
